Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2708 | PH-797804 | 0.6 | uM | 2 | GRO-a | 1821.0 | 49 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 2 | GRO-a | 145.5 | 50 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | GRO-a | 275.0 | 55 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | GRO-a | 53.0 | 79 | ||||
N2645 | IKK16 | 2.0 | uM | 2 | GRO-a | 54.0 | 49 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 2 | GRO-a | 1106.5 | 64 | ||||
RA2708 | IKK16 | 2.0 | uM | 2 | GRO-a | 431.0 | 59 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 2 | GRO-a | 223.0 | 63 | ||||
RA2159 | 2 | GRO-a | 401.0 | 53 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 2 | GRO-a | 74.0 | 37 | ||||
N2645 | 2 | GRO-a | 73.0 | 30 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | GRO-a | 2326.0 | 53 | ||||
RA2708 | 2 | GRO-a | 2162.0 | 45 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | GRO-a | 745.0 | 47 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | GRO-a | 5681.0 | 54 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | GRO-a | 368.0 | 49 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | GRO-a | 922.0 | 62 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | GRO-a | 2705.0 | 45 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | GRO-a | 5965.5 | 58 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | GRO-a | 12214.0 | 34 | |
RA2159 | TNF-a | 100 | ng/mL | 2 | GRO-a | 11765.5 | 52 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | GRO-a | 4967.0 | 51 | |
N2645 | TNF-a | 100 | ng/mL | 2 | GRO-a | 5147.0 | 52 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | GRO-a | 15346.0 | 30 | |
RA2708 | TNF-a | 100 | ng/mL | 2 | GRO-a | 14815.0 | 45 |